MDCX — Medicus Pharma Cashflow Statement
0.000.00%
Last trade - 00:00Annual cashflow statement for Medicus Pharma, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | R2022 December 31st | R2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | USG | USG | USG |
| Status: | fx Final | Final | Final | Final | Final |
| Net Income/Starting Line | -0.142 | -1.69 | -5.31 | -11.2 | -35.4 |
| Non-Cash Items | — | 0.714 | 0.683 | 0.875 | 12.1 |
| Unusual Items | |||||
| Purchased R&D | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 0.059 | -0.079 | 0.473 | 0.033 | 0.57 |
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Payable / Accrued Expenses | |||||
| Cash from Operating Activities | -0.082 | -1.06 | -4.16 | -10.2 | -22.8 |
| Other Investing Cash Flow Items | — | — | — | — | -4.62 |
| Acquisition of Business | |||||
| Cash from Investing Activities | — | — | — | — | -4.62 |
| Financing Cash Flow Items | 0 | 0 | 5.11 | 0 | -0.79 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 0 | 1.25 | 5.61 | 12.7 | 31.9 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -0.082 | 0.189 | 1.45 | 2.44 | 4.54 |